I believe this refers to the clinical trial of arbaclofen, which I think is a variant of Baclofen, for the treatment of Autism by the company Seaside. Reference here: http://www.nytimes.com/2013/06/07/business/an-experimental-drugs-bitter-end.html?hp&_r=0 18.93.14.48